Scientists Advancing Affordable Medicines, Inc. is a nonprofit 501(c)(6) organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. Because we are sharing approaches now for the affordable medicines of tomorrow, we have adopted the tradename SAAMnow.
SAVE THE DATE
Value-Added Medicines Week 2023 ConferenceOctober 16-20, 2023
The 505(b)(2) Platform and Scientists Advancing Affordable Medicines, Inc. are pleased to announce the return of the annual Value Added Medicines Week (VAM Week 2023) Conference on October 16-20, 2023. This year’s conference, The New Horizons of Value-Added Medicines, will be completely virtual and free to all attendees.
Each year the VAM Week conference brings together regulators, developers and marketers of value-added medicines especially repurposed, reformulated, repositioned and reauthorized products. At VAM Week 2023, regulators, sponsors, and payers convene to discuss the state of value-added medicine development, access, marketing, and utilization. This year an esteemed faculty of experts from FDA, industry, healthcare providers and other healthcare organizations will share perspectives on what success and progress looks like in value-added medicine products both in the US and around the world.
The agenda for this year's conference can be viewed at: www.VAMweek.org/2023Program, and will focus on exposing attendees to strategies for growth of their value-added medicine in the US and in markets around the world.
VAM Week is an online conference composed of two main tracks, Development & Business, and a number of satellite symposia. Each year the tracks feature expert presenters from the FDA, commercialization, legal and product development fields. Attendees must register to receive their free seat. This year, all registrants receive free access to all sessions including satellite symposia.
SAAMnow offers individuals the opportunity to potentially impact the availability of affordable medicines through cutting-edge research. SAAMnow is looking for individuals involved/interested in research & development, formulation/manufacturing science, analytical chemistry, clinical science, statistics, quality systems, regulatory science, marketing, and allied disciplines associated with the development, manufacturing, testing, and commercialization of high quality affordable medicines. Affordable medicines are broadly defined as those that take advantage of abbreviated regulatory filing pathways, resulting in development cost savings that can then be passed on to patients. Examples include conventional generic pharmaceuticals, biosimilars, and products filed via hybrid regulatory pathways, such as the 505(b)(2) route.
Our annual membership dues: $50.